We are live on ! Find out more
Thrivent Financial for Lutherans

Thrivent Financial for Lutherans Portfolio holdings

AUM $52.5B
1-Year Est. Return 27.12%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+27.12%
3 Year Est. Return
+79.38%
5 Year Est. Return
+100.59%
10 Year Est. Return
+446.23%
AUM
$51.9B
AUM Growth
+$2.6B
Cap. Flow
-$147M
Cap. Flow %
-0.28%
Top 10 Hldgs %
13.18%
Holding
2,542
New
91
Increased
1,030
Reduced
991
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 16.63%
2 Financials 11.96%
3 Healthcare 9.89%
4 Consumer Discretionary 9.42%
5 Industrials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RRC icon
976
Range Resources
RRC
$9.42B
$3.63M 0.01%
203,284
-6,697
-3% -$144K
WD icon
977
Walker & Dunlop
WD
$1.49B
$3.62M 0.01%
23,987
+323
+1% +$45K
OHI icon
978
Omega Healthcare
OHI
$14.3B
$3.61M 0.01%
121,937
-23,695
-16% -$692K
ENSG icon
979
The Ensign Group
ENSG
$10.7B
$3.59M 0.01%
42,719
+379
+0.9% +$29.5K
BC icon
980
Brunswick
BC
$5.21B
$3.59M 0.01%
35,602
-495
-1% -$48.5K
OI icon
981
O-I Glass
OI
$1.06B
$3.58M 0.01%
298,035
+126,241
+73% +$1.6M
EBS icon
982
Emergent Biosolutions
EBS
$228M
$3.58M 0.01%
82,437
+69,944
+560% +$3.16M
QQQM icon
983
Invesco NASDAQ 100 ETF
QQQM
$102B
0
FN icon
984
Fabrinet
FN
$19.2B
$3.57M 0.01%
30,126
+312
+1% +$34.6K
HQY icon
985
HealthEquity
HQY
$8.9B
$3.56M 0.01%
80,461
+25,005
+45% +$1.46M
VOR icon
986
Vor Biopharma
VOR
$1.25B
$3.56M 0.01%
15,307
+117
+0.8% +$33.7K
GATX icon
987
GATX Corp
GATX
$6.23B
$3.56M 0.01%
34,143
-14,336
-30% -$1.43M
ILCG icon
988
iShares Morningstar Growth ETF
ILCG
$3.27B
0
FMAT icon
989
Fidelity MSCI Materials Index ETF
FMAT
$618M
0
BIT icon
990
BlackRock Multi-Sector Income Trust
BIT
$702M
$3.53M 0.01%
194,415
+20,906
+12% +$389K
SITC icon
991
SITE Centers
SITC
$159M
$3.52M 0.01%
284,746
-1,098
-0.4% -$13.8K
ILTB icon
992
iShares Core 10+ Year USD Bond ETF
ILTB
$592M
0
FDX icon
993
FedEx
FDX
$77B
$3.51M 0.01%
13,148
-1,287
-9% -$309K
UHS icon
994
Universal Health Services
UHS
$10.5B
$3.49M 0.01%
26,907
+20,578
+325% +$2.65M
THO icon
995
Thor Industries
THO
$4.13B
$3.49M 0.01%
33,596
-529
-2% -$57.4K
NUMV icon
996
Nuveen ESG Mid-Cap Value ETF
NUMV
$458M
0
ARKQ icon
997
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.05B
0
BTZ icon
998
BlackRock Credit Allocation Income Trust
BTZ
$958M
$3.47M 0.01%
230,856
+18,499
+9% +$279K
FUL icon
999
H.B. Fuller
FUL
$3.26B
$3.47M 0.01%
42,831
+312
+0.7% +$23K
PRFT
1000
DELISTED
Perficient Inc
PRFT
$3.47M 0.01%
26,805
+187
+0.7% +$24.6K

Similar funds

Thrivent Financial for Lutherans's Q4 2021 Portfolio in Review

As of Q4 2021, Thrivent Financial for Lutherans held 2,542 positions worth $51.9B, up 5.3% from $49.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Thrivent Financial for Lutherans's Q4 2021 filing shows 91 new, 1,030 increased, 991 reduced and 85 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 681,672 shares worth $93.9M. The largest sale was Western Alliance Bancorporation, an estimated $136M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Thrivent Financial for Lutherans's largest Q4 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 681,672 shares worth $93.9M.
  • Thrivent Financial for Lutherans added most to Walmart Inc in Q4 2021, an estimated $164M increase.
  • Thrivent Financial for Lutherans's biggest Q4 2021 reduction was Western Alliance Bancorporation, cutting an estimated $136M.
  • Thrivent Financial for Lutherans fully exited InMode in Q4 2021, selling an estimated $40.5M.
  • Thrivent Financial for Lutherans's ten largest holdings make up 13% of its $51.9B portfolio in Q4 2021.
  • Thrivent Financial for Lutherans opened 91 new positions and closed 85 in Q4 2021.
  • Thrivent Financial for Lutherans's portfolio value rose 5.3% quarter-over-quarter to $51.9B.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2021, filed 16 Feb 2022.